Regulatory CD4+CD25+ T cells and macrophages: Communication between two regulators of effector T cells

Inflammation Research

Volumn 57, Issue 12, 2008, Pages 564-570

  Zhen, Y ^a,b   Zheng, J ^b,c   Zhao, Y ^a,b  

^a INSTITUTE OF ZOOLOGY   (China)

^b China US Joint Research Center for Life Sciences   (China)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Effector T cells; Interaction; Macrophages; Regulatory T cells

Indexed keywords

AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL COMMUNICATION; CELL INTERACTION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; CHEMOKINES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MACROPHAGES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 58149129674     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-008-7234-3     Document Type: Review

References (70)

1. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-1164.
2. Yi H, Zhen Y, Jiang L, Zheng J, Zhao Y: The phenotypic characterization of naturally occurring regulatory CD4+CD25+ T cells. Cell Mol Immunol 2006; 3: 189-195.
3. Zhang L, Zhao Y: The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road. J Cell Physiol 2007; 211: 590-597.
4. Walker MR, Carson BD, Nepom GT, Ziegler SF, Buckner JH: De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci U S A 2005; 102: 4103-4108.
5. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 2003; 112: 1437-1443.
6. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA: Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 2004; 199: 971-979.
7. van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50: 2775-2785.
8. Cao L, Hudson CA, Lawrence DA: Immune changes during acute cold/restraint stress-induced inhibition of host resistance to Listeria. Toxicol Sci 2003; 74: 325-334.
9. Mudd PA, Teague BN, Farris AD: Regulatory T cells and systemic lupus erythematosus. Scand J Immunol 2006; 64: 211-218.
10. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199-210.
11. Viehl CT, Moore TT, Liyanage UK, Frey DM, Ehlers JP, Eberlein TJ, Goedegebuure PS, Linehan DC: Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann Surg Oncol 2006; 13: 1252-1258.
12. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN: Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 2004; 200: 771-782.
13. Gallimore A, Sakaguchi S: Regulation of tumour immunity by CD25+ T cells. Immunology 2002; 107: 5-9.
14. Shimizu T, Ohkawara A, Mizue Y, Nishihira J: Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts. Semin Thromb Hemost 1999; 25: 569-573.
15. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH: Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002; 168: 4272-4276.
16. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420: 502-507.
17. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS: Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003; 71: 1755-1762.
18. Ralainirina N, Poli A, Michel T, Poos L, Andres E, Hentges F, Zimmer J: Control of natural killer (NK) cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 2006.
19. Hoves S, Krause SW, Schutz C, Halbritter D, Scholmerich J, Herfarth H, Fleck M: Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol 2006; 177: 2691-2698.
20. Kubo T, Hatton RD, Oliver J, Liu X, Elson CO, Weaver CT: Regulatory T cell suppression and anergy are differentially regulated by proinflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004; 173: 7249-7258.
21. Gong N, Zhao Y, Dong C, Chen ZK: Negative costimulatory molecules: the proximal of regulatory T cells? Med Hypotheses 2006; 67: 841-847.
22. Yamazaki S, Inaba K, Tarbell KV, Steinman RM: Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity. Immunol Rev 2006; 212: 314-329.
23. Ghiringhelli F, Menard C, Martin F, Zitvogel L: The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression. Immunol Rev 2006; 214: 229-238.
24. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197: 111-119.
25. Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003;170:3939-3943.
26. Liu H, Hu B, Xu D, Liew FY: CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol 2003; 171: 5012-5017.
27. Santucci L, Agostini M, Bruscoli S, Mencarelli A, Ronchetti S, Ayroldi E, Morelli A, Baldoni M, Riccardi C: GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice. Gut 2007; 56: 52-60.
28. Mahajan D, Wang Y, Qin X, Wang Y, Zheng G, Wang YM, Alexander SI, Harris DC: CD4+CD25+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol 2006; 17: 2731-2741.
29. Taams LS, van Amelsfort JM, Tiemessen MM, Jacobs KM, de Jong EC, Akbar AN, Bijlsma JW, Lafeber FP: Modulation of monocyte/ macrophage function by human CD4+CD25+ regulatory T cells. Hum Immunol 2005; 66: 222-230.
30. Kryczek I, Wei S, Zou L, Zhu G, Mottram P, Xu H, Chen L, Zou W: Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells. J Immunol 2006; 177: 40-44.
31. Mirza N, Gabrilovich D: Comment on "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells". J Immunol 2007; 178: 4705-4706; author reply 4706.
32. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJ, John S, Taams LS: CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007; 104: 19446-19451.
33. Miwa N, Hayakawa S, Miyazaki S, Myojo S, Sasaki Y, Sakai M, Takikawa O, Saito S: IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-gamma increase in normal pregnancy but decrease in spontaneous abortion. Mol Hum Reprod 2005; 11: 865-870.
34. Venet F, Pachot A, Debard AL, Bohe J, Bienvenu J, Lepape A, Powell WS, Monneret G: Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism. J Immunol 2006; 177: 6540-6547.
35. Matlack R, Yeh K, Rosini L, Gonzalez D, Taylor J, Silberman D, Pennello A, Riggs J: Peritoneal macrophages suppress T-cell activation by amino acid catabolism. Immunology 2006; 117: 386-395.
36. Taylor MD, Harris A, Nair MG, Maizels RM, Allen JE: F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection. J Immunol 2006; 176: 6918-6927.
37. Spina CA, Dorey F, Vescera C, Brosman S, Fahey JL: Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients. Cancer Res 1981; 41: 4324-4330.
38. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL: Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 1999; 189: 1363-1372.
39. Sternberg J, McGuigan F: Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection. Eur J Immunol 1992; 22: 2741-2744.
40. Gabbai FB, Boggiano C, Peter T, Khang S, Archer C, Gold DP, Kelly CJ: Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997; 159: 6266-6275.
41. Fenyk-Melody JE, Garrison AE, Brunnert SR, Weidner JR, Shen F, Shelton BA, Mudgett JS: Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J Immunol 1998; 160: 2940-2946.
42. Kahl KG, Schmidt HH, Jung S, Sherman P, Toyka KV, Zielasek J: Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 2004; 358: 58-62.
43. Juedes AE, Ruddle NH: Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 2001; 166: 5168-5175.
44. Terabe M, Shimizu M, Mabuchi A, Matui S, Morikawa H, Kaneda K, Kakiuchi T, Yokomuro K: Unresponsiveness of intrahepatic lymphocytes to bacterial superantigen: rapid development of suppressive Mac-1(high) cells in the mouse liver. Hepatology 2000; 32: 507-513.
45. Atochina O, Daly-Engel T, Piskorska D, McGuire E, Harn DA: A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism. J Immunol 2001; 167: 4293-4302.
46. Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K: Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J Immunol 2005; 175: 1586-1592.
47. Magnus T, Schreiner B, Korn T, Jack C, Guo H, Antel J, Ifergan I, Chen L, Bischof F, Bar-Or A, Wiendl H: Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 2005; 25: 2537-2546.
48. Ochando JC, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, Angeli V, Li Y, Boros P, Ding Y, Jessberger R, Trinchieri G, Lira SA, Randolph GJ, Bromberg JS: Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652-662.
49. Sun Y, Ge BS, Kasai M, Diffendaffer C, Parks N, Li H, Peng J, Langnas AN, Zhao Y: Induction of regulatory T cells from mature T cells by allogeneic thymic epithelial cells in vitro. Transpl Int 2006; 19: 404-414.
50. Wang RF, Peng G, Wang HY: Regulatory T cells and Toll-like receptors in tumor immunity. Semin Immunol 2006;18:136-142.
51. Liu Y, Teige I, Birnir B, Issazadeh-Navikas S: Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006; 12: 518-525.
52. [The role of regulatory cells CD4+CD25+ in the development of chronic infective diseases]. Vestn Ross Akad Med Nauk 2006: 24-29.
53. Kosiewicz MM, Alard P: Tolerogenic antigen-presenting cells: regulation of the immune response by TGF-beta-treated antigen-presenting cells. Immunol Res 2004; 30: 155-170.
54. Kosiewicz MM, Alard P, Liang S, Clark SL: Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand. Int Immunol 2004; 16: 697-706.
55. Alard P, Clark SL, Kosiewicz MM: Mechanisms of tolerance induced by TGF beta-treated APC: CD4 regulatory T cells prevent the induction of the immune response possibly through a mechanism involving TGF beta. Eur J Immunol 2004; 34: 1021-1030.
56. Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH: Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006; 66: 1123-1131.
57. Lin HH, Faunce DE, Stacey M, Terajewicz A, Nakamura T, Zhang-Hoover J, Kerley M, Mucenski ML, Gordon S, Stein-Streilein J: The macrophage F4/80 receptor is required for the induction of antigen-specific efferent regulatory T cells in peripheral tolerance. J Exp Med 2005; 201: 1615-1625.
58. Kwidzinski E, Mutlu LK, Kovac AD, Bunse J, Goldmann J, Mahlo J, Aktas O, Zipp F, Kamradt T, Nitsch R, Bechmann I: Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model. J Neural Transm Suppl 2003: 29-49.
59. Wiegard C, Frenzel C, Herkel J, Kallen KJ, Schmitt E, Lohse AW: Murine liver antigen presenting cells control suppressor activity of CD4+CD25+ regulatory T cells. Hepatology 2005; 42: 193-199.
60. Huehn J, Hamann A: Homing to suppress: address codes for Treg migration. Trends Immunol 2005; 26: 632-636.
61. Huehn J, Siegmund K, Hamann A: Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets. Curr Top Microbiol Immunol 2005; 293: 89-114.
62. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D: Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells. J Exp Med 2001; 194: 847-853.
63. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
64. Columba-Cabezas S, Serafini B, Ambrosini E, Sanchez M, Penna G, Adorini L, Aloisi F: Induction of macrophage-derived chemokine/ CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J Neuroimmunol 2002; 130: 10-21.
65. Bystry RS, Aluvihare V, Welch KA, Kallikourdis M, Betz AG: B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001; 2: 1126-1132.
66. Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, Maraver A, Lafaille JJ, Dustin ML: Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 2006; 203: 505-511.
67. Kawakami N, Nagerl UV, Odoardi F, Bonhoeffer T, Wekerle H, Flugel A: Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 2005; 201: 1805-1814.
68. Mosser DM: The many faces of macrophage activation. J Leukoc Biol 2003; 73: 209-212.
69. Goerdt S, Orfanos CE: Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
70. Gordon S: Alternative activation of macrophages. Nat Rev Immunol 2003; 3: 23-35.